This statistic shows the revenue of the industry “Natural drugs and chinese medicines style medicines“ in Japan from 2012 to 2018, with a forecast to 2024. It is projected that the revenue of Natural drugs and chinese medicines style medicines in Japan will amount to approximately 3,0 billion U.S. Dollars by 2024.
Industry revenue of “Natural drugs and chinese medicines style medicines“ in Japan from 2012 to 2024 (in billion U.S. Dollars)
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Industrial production index of pharmaceutic and medicinal chemicals Vietnam 2012-2022
- Premium Statistic Industry revenue of “Medical product preparations“ in Japan 2012-2024
- Premium Statistic Forecast: revenue pharmaceutical preparation manufacture France 2008-2020
- Premium Statistic Forecast: revenue pharmaceutical preparation manufacture Germany 2008-2020
- Premium Statistic Forecast: revenue pharmaceutical preparation manufacture Ireland 2009-2020
- Premium Statistic PPI for chemicals and chemical products Thailand 2009-2022
- Premium Statistic Chemicals and pharmaceuticals production growth in Russia 2017-2022
- Basic Statistic Revenue of the chemicals manufacturing industry in the UK 2008-2021
- Basic Statistic Personnel costs of the chemical manufacturing industry in the UK 2010-2021
- Basic Statistic Olon worldwide revenue 2016-2021
About the region
10
- Premium Statistic Fatal manufacturing industry accidents in Japan 2020, by field
- Premium Statistic FDI flows into Japan 2014-2023
- Premium Statistic Construction order value from the manufacturing industry in Japan FY 2013-2022
- Premium Statistic Final energy consumption industrial sector Japan FY 2022, by industry
- Premium Statistic Final energy consumption industrial and commercial sector Japan FY 2013-2022
- Premium Statistic Inward FDI flows in the chemicals and pharmaceuticals industry in Japan 2014-2023
- Premium Statistic Number of new drugs approved by PMDA Japan FY 2014-2022
- Premium Statistic Number of pharmaceutical products approved by PMDA Japan FY 2022, by type
- Premium Statistic Number of prescription drugs approved by PMDA Japan FY 2015-2022, by type
- Premium Statistic Number of BTC and OTC drugs approved by PMDA Japan FY 2013-2022
Other regions
10
- Premium Statistic Production value of modern medicine Thailand 2021, by ATC
- Basic Statistic Number of enterprises in the UK pharmaceutical industry 2013-2019, by turnover
- Premium Statistic Manufacture of pharmaceutical preparations revenue in Croatia 2012-2022
- Premium Statistic Manufacture of pharmaceutical preparations revenue in Bulgaria 2010-2022
- Premium Statistic Manufacture of pharmaceutical preparations revenue in Belgium 2010-2022
- Basic Statistic PPI of pharmaceuticals and medicinal products in Vietnam 2015-2022
- Premium Statistic Contribution of manufacturing to the GDP in Abu Dhabi 2013-2019
- Premium Statistic Monthly PPI of the utilities sector in Ghana 2019-2022
- Premium Statistic GDP for manufacturing in Kuwait 2014-2019
- Premium Statistic Commercial aircraft engine manufacturers: market share in North America 2020
Related statistics
10
- Premium Statistic Industry revenue of “manufacture of pharmaceutical preparations“ in Germany 2012-2025
- Premium Statistic Industry revenue of “manufacture of pharmaceutical preparations“ in Greece 2012-2025
- Premium Statistic Industry revenue of “manufacture of pharmaceutical preparations“ in Denmark 2012-2025
- Premium Statistic Industry revenue of “manufacture of pharmaceutical preparations“ in Hungary 2012-2025
- Premium Statistic Industry revenue of “manufacture of pharmaceutical preparations“ in Switzerland 2012-2025
- Premium Statistic Industry revenue of “manufacture of pharmaceutical preparations“ in Bulgaria 2012-2025
- Premium Statistic Industry revenue of “manufacture of pharmaceutical preparations“ in Romania 2012-2025
- Premium Statistic Industry revenue of “manufacture of pharmaceutical preparations“ in the Netherlands 2012-2025
- Premium Statistic Industry revenue of “manufacture of pharmaceutical preparations“ in Belgium 2012-2025
- Premium Statistic Industry revenue of “manufacture of pharmaceutical preparations“ in Italy 2012-2025
Further related statistics
10
- MorphoSys' revenue 2006-2023
- MorphoSys' research & development expenditure 2006-2023
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co total assets 2009-2023
- Merck & Co cash dividends declared 2006-2023
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
Further Content: You might find this interesting as well
Statistics
- MorphoSys' revenue 2006-2023
- MorphoSys' research & development expenditure 2006-2023
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co total assets 2009-2023
- Merck & Co cash dividends declared 2006-2023
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
Statistics Bureau of Japan. (September 15, 2020). Industry revenue of “Natural drugs and chinese medicines style medicines“ in Japan from 2012 to 2024 (in billion U.S. Dollars) [Graph]. In Statista. Retrieved May 11, 2024, from https://www.statista.com/forecasts/414172/natural-drugs-and-chinese-medicines-style-medicines-revenue-in-japan
Statistics Bureau of Japan. "Industry revenue of “Natural drugs and chinese medicines style medicines“ in Japan from 2012 to 2024 (in billion U.S. Dollars)." Chart. September 15, 2020. Statista. Accessed May 11, 2024. https://www.statista.com/forecasts/414172/natural-drugs-and-chinese-medicines-style-medicines-revenue-in-japan
Statistics Bureau of Japan. (2020). Industry revenue of “Natural drugs and chinese medicines style medicines“ in Japan from 2012 to 2024 (in billion U.S. Dollars). Statista. Statista Inc.. Accessed: May 11, 2024. https://www.statista.com/forecasts/414172/natural-drugs-and-chinese-medicines-style-medicines-revenue-in-japan
Statistics Bureau of Japan. "Industry Revenue of “natural Drugs and Chinese Medicines Style Medicines“ in Japan from 2012 to 2024 (in Billion U.S. Dollars)." Statista, Statista Inc., 15 Sep 2020, https://www.statista.com/forecasts/414172/natural-drugs-and-chinese-medicines-style-medicines-revenue-in-japan
Statistics Bureau of Japan, Industry revenue of “Natural drugs and chinese medicines style medicines“ in Japan from 2012 to 2024 (in billion U.S. Dollars) Statista, https://www.statista.com/forecasts/414172/natural-drugs-and-chinese-medicines-style-medicines-revenue-in-japan (last visited May 11, 2024)
Industry revenue of “Natural drugs and chinese medicines style medicines“ in Japan from 2012 to 2024 (in billion U.S. Dollars) [Graph], Statistics Bureau of Japan, September 15, 2020. [Online]. Available: https://www.statista.com/forecasts/414172/natural-drugs-and-chinese-medicines-style-medicines-revenue-in-japan